NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Thursday that its third quarter revenues rose 7 percent year over year, driven by strength in sales of its eSensor XT-8 and ePlex molecular diagnostics systems.

For the three months ended Sept. 30, the firm reported revenues of $11.6 million, up from $10.8 million a year ago, but short of the consensus Wall Street estimate of $14.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.